Telix Pharmaceuticals Ltd
F:T3X
Telix Pharmaceuticals Ltd
F:T3X
Price:
9.32
EUR
-3.3%
Market Closed
Market Cap:
€3.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Telix Pharmaceuticals Ltd
F:T3X
|
AU |
|
H
|
Hwa Tai Industries Bhd
KLSE:HWATAI
|
MY |
|
G
|
Greencore Group PLC
F:GCG
|
IE |
|
Compagnie De l'odet SE
LSE:0OPN
|
FR |
|
C
|
Cybeats Technologies Inc
F:P4T
|
CA |
|
Vericel Corp
NASDAQ:VCEL
|
US |
|
E
|
EUROKAI GmbH & Co KgaA
F:EUK3
|
DE |
|
P
|
PMPG Polskie Media SA
WSE:PGM
|
PL |
|
N
|
NHN Bugs Corp
KOSDAQ:104200
|
KR |
Multiples-Based Value
The Multiples-Based Value for 
Telix Pharmaceuticals Ltd (T3X) under the Base Case is hidden
EUR.
Compared with the current market price of 9.32 EUR, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
T3X Multiples-Based Value
LOCKED